GRI

GRI BIO, INC.

GRI · CIK 1824293 · Annual (10-K) · Last 5 years

Financial Trends

Revenue
20212025
Net Income−$12M
20212025
Operating CF−$10M
20212025
Free Cash Flow−$10M
20212025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕
Revenue————$0.0B
Cost of Revenue—————
Gross Profit—————
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense—————
Operating Income$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-121.80$-55.21$-28.25$-0.69$-1.42
EPS (Diluted)$-121.80$-55.21$-28.25$-0.69$-1.42

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕
Total Assets$0.0B$0.0B$0.0B$0.0B$0.0B
Current Assets$0.0B$0.0B$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.0B$0.0B$0.0B$0.0B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$-0.0B$0.0B$-0.0B$0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B—$0.0B
Financing Cash Flow$0.0B$0.0B$0.0B$0.0B$0.0B
← Companies